Testing effectiveness (Phase 2)WithdrawnNCT04987996
What this trial is testing
GR-MD-02 + Pembrolizumab Versus Pembrolizumab Monotherapy in Melanoma and Squamous Cell Head and Neck Cancer Patients
Who this might be right for
Metastatic MelanomaHead and Neck Squamous Cell Carcinoma
Providence Health & Services